Beam Therapeutics Inc
BEAMLatest QuantConomy context for BEAM: asset profile, market coverage, scored signals, and source-linked SEC insider filings when available.
Beam Therapeutics Inc
QuantConomy has a structured record for BEAM. More descriptive asset metadata will appear here when the platform record includes it.
- Symbol
- BEAM
- Name
- Beam Therapeutics Inc
- Coverage
- 3 market/data records
- Sources
- fmp alpaca alphavantage sec nasdaq binance
Recent signals for BEAM
Scored rows are pulled from the same signal API used by the digests.
| Signal | Direction | Score | Observed | Reason |
|---|---|---|---|---|
| large sale | bearish | 45 | Jun 29, 06:36 PM | FMR LLC (10% Owner) sold BEAM shares ($1.17M) - 33,372 shares - [weak bearish signal] |
| earnings release | neutral | 40 | Jan 12, 12:00 AM | BEAM filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-01-12. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
| earnings release | neutral | 40 | Feb 24, 12:00 AM | BEAM filed an earnings release (8-K Item 2.02 - Results of Operations and Financial Condition) on 2026-02-24. Release-event signal only: confirms results were published, not the figures vs. estimates (no surprise/guidance read). |
EARNINGS signals are experimental: currently limited to neutral pre-earnings calendar awareness (no transcript analysis).
PRICE signals are experimental: realized 30-day directional accuracy is ~18% (short-horizon price moves tend to mean-revert). They are automatically down-weighted in composite scores but served raw here. Do not use them as standalone trade advice.
Market coverage
| Market | Exchange | Source | Asset record |
|---|---|---|---|
| BEAM | NASDAQ | fmp | Beam Therapeutics Inc. |
| BEAM | NASDAQ | alpaca | Beam Therapeutics Inc. Common Stock |
| BEAM | NASDAQ | alphavantage | Beam Therapeutics Inc |
Recent insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Jun 29, 2026 | Evans John M. | CEO | exercise | 18,663 | $0.67 | $12,504 | 4 on EDGAR |
| Jun 25, 2026 | FMR LLC | 10% owner | sale | 33,372 | $35.12 | $1,172,025 | 4 on EDGAR |
| Jun 17, 2026 | Ciaramella Giuseppe | President | exercise | 6,505 | $0.67 | $4,358 | 4 on EDGAR |
| Jun 3, 2026 | Walsh Kathleen E | Director | grant | 19,676 | — | — | 4 on EDGAR |
| Jun 3, 2026 | Guindo Chirfi | Director | grant | 19,676 | — | — | 4 on EDGAR |
| Jun 3, 2026 | Fishman Mark | Director | grant | 19,676 | — | — | 4 on EDGAR |
| Jun 3, 2026 | MARAGANORE JOHN | Director | grant | 19,676 | — | — | 4 on EDGAR |
| Jun 3, 2026 | Shaw Christi | Director | grant | 19,676 | — | — | 4 on EDGAR |
| Jun 3, 2026 | COOPER GRAHAM K | Director | grant | 19,676 | — | — | 4 on EDGAR |
| Apr 1, 2026 | Evans John M. | CEO | sale | 30,078 | $24.58 | $739,317 | 4 on EDGAR |
| Apr 1, 2026 | Bellon Christine | Chief Legal Officer | sale | 5,956 | $24.58 | $146,398 | 4 on EDGAR |
| Apr 1, 2026 | Ciaramella Giuseppe | President | sale | 11,810 | $24.58 | $290,290 | 4 on EDGAR |
| Apr 1, 2026 | Simon Amy | Chief Medical Officer | sale | 6,700 | $24.58 | $164,686 | 4 on EDGAR |
| Apr 1, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | sale | 3,242 | $24.58 | $79,688 | 4 on EDGAR |
| Mar 31, 2026 | Cavanagh Bethany J | SVP, Finance and Treasurer | grant | 20,000 | $0.00 | $0 | 4 on EDGAR |
| Mar 31, 2026 | Ciaramella Giuseppe | President | grant | 40,000 | $0.00 | $0 | 4 on EDGAR |
| Mar 31, 2026 | Bellon Christine | Chief Legal Officer | grant | 20,000 | $0.00 | $0 | 4 on EDGAR |
| Mar 31, 2026 | Simon Amy | Chief Medical Officer | grant | 31,750 | $0.00 | $0 | 4 on EDGAR |
| Mar 31, 2026 | Emany Sravan Kumar | Chief Financial Officer | grant | 31,750 | $0.00 | $0 | 4 on EDGAR |
| Mar 30, 2026 | Evans John M. | CEO | exercise | 25,000 | $0.67 | $16,750 | 4 on EDGAR |
Source: SEC filings via QuantConomy. Not investment advice.
Query BEAM context like a database.
These rows come from the QuantConomy signal, asset, market, and SEC filings API surfaces, also available to AI agents over MCP.
More: All insider trades · How to read a Form 4 · API access